Search Results - "Aras, Girish"

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis by Papp, Kim A, Leonardi, Craig, Menter, Alan, Ortonne, Jean-Paul, Krueger, James G, Kricorian, Gregory, Aras, Girish, Li, Juan, Russell, Chris B, Thompson, Elizabeth H.Z, Baumgartner, Scott

“…In this 12-week, phase 2 trial, an anti–interleukin-17–receptor antibody was effective in treating moderate-to-severe psoriasis. Adverse events included…”
Get full text

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results by Kimball, Alexa B., MD, Rothman, Kenneth J., DrPH, Kricorian, Gregory, MD, Pariser, David, MD, Yamauchi, Paul S., MD, PhD, Menter, Alan, MD, Teller, Craig F., MD, Aras, Girish, PhD, Accortt, Neil A., PhD, Hooper, Michele, MD, Rice, Kara Creamer, MS, Gelfand, Joel M., MD, MSCE

“…Background OBSERVE-5 was a 5-year Food and Drug Administration–mandated surveillance registry of patients with psoriasis. Objective We sought to assess…”
Get full text

Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis by Langley, Richard G., Kasichayanula, Sree, Trivedi, Mona, Aras, Girish A., Kaliyaperumal, Arunan, Yuraszeck, Theresa, Gibbs, John, Gibbs, Megan, Kricorian, Greg, Paller, Amy S.

“…Etanercept has been recently approved in the United States for the treatment of moderate to severe plaque psoriasis in patients aged 4–17 years. The objective…”
Get full text

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting by Mease, Philip J., Accortt, Neil A., Rebello, Sabrina, Etzel, Carol J., Harrison, Ryan W., Aras, Girish A., Gharaibeh, Mahdi M. F., Greenberg, Jeffrey D., Collier, David H.

“…This study described treatment patterns in a psoriatic arthritis (PsA) patient registry for new or ongoing tumor necrosis factor inhibitor (TNFi) monotherapy,…”
Get full text

Defining and characterizing sustained remission in patients with rheumatoid arthritis by Curtis, Jeffrey R., Trivedi, Mona, Haraoui, Boulos, Emery, Paul, Park, Grace S., Collier, David H., Aras, Girish A., Chung, James

“…The objective of this study is to characterize stability and clinical features of patients with rheumatoid arthritis (RA) in sustained remission. Combination…”
Get full text

Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial by Cohen, Stanley, Samad, Ahmed, Karis, Elaine, Stolshek, Bradley S., Trivedi, Mona, Zhang, Hao, Aras, Girish A., Kricorian, Greg, Chung, James B.

“…Introduction Etanercept, a tumor necrosis factor inhibitor, is used to treat rheumatoid arthritis (RA) and psoriatic arthritis (PsA), and is administered via…”
Get full text

OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis by Kimball, Alexa B., MD, MPH, Pariser, David, MD, Yamauchi, Paul S., MD, PhD, Menter, Alan, MD, Teller, Craig F., MD, Shi, Yifei, MS, Yong, Mellissa, PhD, Creamer, Kara, MS, Hooper, Michele, MD, Aras, Girish, PhD, Kricorian, Gregory, MD, Gelfand, Joel M., MD, MSCE

“…Background Etanercept is approved for the treatment of chronic moderate to severe plaque psoriasis in adults. Objective We sought to evaluate the long-term…”
Get full text

Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast by Bagel, Jerry, Samad, Ahmed S, Stolshek, Bradley S, Aras, Girish A, Chung, James B, Kricorian, Gregory, Kircik, Leon H

“…Response to etanercept therapy in patients who have failed apremilast therapy has not been well characterized. In this multicenter, open-label, single-arm,…”
Get more information

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) by Mease, Philip J, Gladman, Dafna D, Samad, Ahmed S, Coates, Laura C, Liu, Lyrica X H, Aras, Girish A, Collier, David H, Chung, James B

“…ObjectiveTo evaluate the efficacy of etanercept and methotrexate as monotherapies and as combination therapy in subjects with active psoriatic arthritis…”
Get full text

Superiority, noninferiority, equivalence, and bioequivalence-revisited by ARAS, Girish

Get full text

Asymptotic Expansions for the Moments of a Randomly Stopped Average by Aras, Girish, Woodroofe, Michael

“…Let S1, S2,⋯ denote a driftless random walk with values in an inner product space W; let Z1, Z2,⋯ denote a perturbed random walk of the form$Z_n=n+\langle…”
Get full text

Adaptive Designs for Optimal Age Replacement Policy by Aras, Girish

“…Consider a system that is subject to failure and must be replaced when this occurs. If it costs less to replace the system in advance before failure, it may be…”
Get full text